TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Clinical trial NCT04669067 · UNKNOWN

Trial details

NCT number: NCT04669067
Sponsor: Telios Pharma, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2021-03-31
Primary completion: 2024-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.